Similarly, oral trimetazidine (20 mg three times a day) among volunteers with diabetes and idiopathic dilated cardiomyopathy maintained CRP levels stable over 6 months compared to a placebo control that showed increased CRP [163]. This evidence concerns the gene CRP and idiopathic dilated cardiomyopathy.